Table 4.
Trends in Physician Supply per 100,000 people in States with Strong Malpractice Caps on Non-Economic Damages (≤$250,000) Before and After Implementation, by Physician Risk Type and Age
| Number of Years Before or After Damage Cap |
High-Risk, <35 Years of Age |
High-Risk, 35–54 Years of Age |
High-Risk, ≥55 Years of Age |
Low-Risk, <35 Years of Age |
Low-Risk, 35–54 Years of Age |
Low-Risk, ≥55 Years of Age |
|---|---|---|---|---|---|---|
| 3 Years Before | −0.11 [0.83] | 0.22 [0.77] | 1.17 [0.74] | −0.02 [0.51] | 1.11 [0.47] | 0.46 [0.41] |
| 2 Years Before | −0.03 [0.28] | 0.61 [0.82] | 0.28 [0.51] | 0.37 [0.42] | −0.38 [0.39] | 0.4 [0.20] |
| 1 Year Before | −0.9 [0.64] | 0.1 [0.63] | 0.08 [0.55] | 0.01 [0.49] | −0.37 [0.52] | 0.09 [0.15] |
| Year of Non-Economic Damage Cap | 1.05 [2.69] | 7.10* [2.95] | −1.1 [1.47] | 2.23 [1.08] | −1.9 [2.07] | 3.1 [1.33] |
| 1 Year After | 0.03 [0.81] | 2.07* [0.83] | 0.46 [0.86] | 0.71 [0.82] | −0.92 [0.61] | 1.24* [0.38] |
| 2 Years After | 0.52 [1.00] | 0.73 [0.52] | 0.22 [0.45] | 0.15 [0.78] | −0.52 [0.62] | 0.82** [0.19] |
| 3 Years After | 0.31 [0.68] | 1.46 [0.63] | −0.81 [0.70] | 0.65 [0.47] | −0.26 [0.32] | 0.25 [0.43] |
| 4 Years After and Beyond | 1.48 [0.72] | 2.18* [0.78] | −0.09 [0.35] | 0.08 [1.09] | −0.59 [0.45] | 1.02* [0.39] |
| p-value for Pre-Trend | 0.364 | 0.678 | 0.15 | 0.718 | 0.001 | 0.263 |
| Linear Combination of Post-Cap Coefficients | 3.394 [5.229] | 13.549** [3.535] | −1.315 [2.777] | 3.826 [3.496] | −4.187 [3.12] | 6.434* [2.185] |
| Sample | 88 | 88 | 88 | 88 | 88 | 88 |
| Mean | 16.565 | 56.387 | 37.777 | 11.849 | 40.513 | 25.621 |
| State Characteristics | Yes | Yes | Yes | Yes | Yes | Yes |
| Year Fixed Effects | Yes | Yes | Yes | Yes | Yes | Yes |
| State Fixed Effects | Yes | Yes | Yes | Yes | Yes | Yes |
Notes: State characteristics include annual income, 36 age-gender cohorts, and all of the additional malpractice reform variables included in Table 1.
Significant at the 0.1 percent level.
Significant at the 1 percent level.
Significant at the 5 percent level.